IN8bio (INAB)
(Delayed Data from NSDQ)
$1.18 USD
-0.03 (-2.48%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $1.20 +0.02 (1.69%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INAB 1.18 -0.03(-2.48%)
Will INAB be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for INAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INAB
Here's Why IN8bio, Inc. (INAB) Could be Great Choice for a Bottom Fisher
IN8bio, Inc. (INAB)'s Technical Outlook is Bright After Key Golden Cross
INAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
IN8bio, Inc. (INAB) Is Up 37.87% in One Week: What You Should Know
Other News for INAB
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB)
IN8bio initiated with bullish view at Laidlaw, here's why
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR) and IN8bio (INAB)
INAB Stock Earnings: IN8bio Misses EPS for Q4 2023
IN8bio GAAP EPS of -$0.22